Elsevier

The Lancet

Volume 342, Issue 8877, 16 October 1993, Pages 954-958
The Lancet

Articles
Molecular analysis and clinical correlations of the Huntington's disease mutation

https://doi.org/10.1016/0140-6736(93)92002-BGet rights and content

Abstract

Summary

The genetic mutation underlying Huntington's disease (HD) has been identified as an expansion and instability of a specific CAG repeat sequence in a gene (IT15) on chromosome 4. We have investigated the relation of the phenotype of HD to this molecular defect and assessed the feasibility of HD mutation analysis in diagnosis and prediction.

Analysis of DNA from 449 HD patients (351 familial and 98 apparently isolated cases) revealed the mutation in more than 95% of patients from both groups. No molecular difference was found between patients presenting with psychiatric symptoms and those in whom chorea or other motor defects were the principal features; additionally, there was a wide range of age at onset for any specific repeat number, though the small group with juvenile onset and presenting with rigidity showed the largest expansions.

The findings suggest that molecular analysis will be an accuarte ans specific diagnostic test for HD and valuable in presymptomatic detection in individuals at risk. Howecer, such testing, will require considerable caution to avoid serious difficulties, the well-established guideliness developped for the use of linked markers in relation to the prediction of HD should continue to be followed, though they will require reassessment in relation to use in diagnosis. Lancet 1993, 342: 954–58

References (17)

There are more references available in the full text version of this article.

Cited by (78)

  • Aberrant liquid-liquid phase separation and amyloid aggregation of proteins related to neurodegenerative diseases

    2022, International Journal of Biological Macromolecules
    Citation Excerpt :

    A trinucleotide repeat CAG expansion (which is translated to a homopolymeric glutamine tract in the encoded protein) over a particular threshold in the huntingtin gene (HTT) coding for the huntingtin protein (HTT) is linked to the Huntington's disease (HD, OMIM 143100), which is one of more than 50 human diseases caused by the expanded short tandem repeats [206–208]. Although non-expanded HTT gene possessing 5–35 CAG repeats is not pathogenic, the expanded HTT gene containing 36 + repeats is associated with a significantly increased risk of developing HD [209], where the age of disease onset is largely determined by the length of the CAG tract [210–212]. Despite the fact that the non-expanded HTT gene codes for the mostly non-aggregating HTT protein, the protein with extended polyQ tract is characterized by enhanced aggregation propensity and altered biological activities [213–218].

  • Principles and Practice of Movement Disorders

    2021, Principles and Practice of Movement Disorders
  • Huntington’s disease: Clinical features, disease mechanisms, and management

    2020, Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Volume 2
  • Huntington Disease

    2014, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition
  • Molecular biology of Huntington's disease

    2011, Handbook of Clinical Neurology
    Citation Excerpt :

    Since onset of symptoms typically occurs after childbearing years, HD gene carriers can unknowingly pass the gene to their children. However, with the advent of gene testing (MacMillan et al., 1993), patients with a family history of the disease can test for the presence of the mutated copy of the disease gene. Yet, gene testing for a disease which has no effective treatments is fraught with ethical and emotional implications, particularly for those alleles within the intermediate range (reviewed in Williams and Schutte, 2000; Semaka et al., 2006).

View all citing articles on Scopus
View full text